PLASMASAFE ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
274骨形成不全症1

274. 骨形成不全症


臨床試験数 : 87 薬物数 : 103 - (DrugBank : 20) / 標的遺伝子数 : 14 - 標的パスウェイ数 : 76
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2015-002622-39-IT
(EUCTR)
18/11/201527/05/2021Experimental Study Protocol on Treatment with plasma transfusions in Patients affected by type VI Osteogenesis ImperfectaExperimental Study Protocol on Treatment with plasma transfusions in Patients affected by type VI Osteogenesis Imperfecta - Experimental Study Protocol on Treatment with plasma transfusions in Patients affected by type VI Os type VI Osteogenesis Imperfecta
MedDRA version: 20.0;Level: PT;Classification code 10031243;Term: Osteogenesis imperfecta;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
Trade Name: PLASMASAFE - SOLUZIONE PER INFUSIONE 1 SACCA DA 200 ML
Product Name: PLASMASAFE
INN or Proposed INN: 00244301
AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONANULLNot RecruitingFemale: yes
Male: yes
10Phase 2Italy